AMENDMENT #2 TO AMENDED AND RESTATED BUSINESS TRANSFER AND SUBSCRIPTION AGREEMENTTransfer and Subscription Agreement • August 17th, 2018 • Entasis Therapeutics LTD • Pharmaceutical preparations
THIS AMENDMENT #2 TO AMENDED AND RESTATED BUSINESS TRANSFER AND SUBSCRIPTION AGREEMENT (this “Amendment”) is made and entered into as of January 30, 2018 by and among ASTRAZENECA AB (PUBL), a company incorporated in Sweden under no. 556011-7482 (the “Sweden Seller”), ASTRAZENECA UK LIMITED, a company incorporated in England under no. 3674842 (the “UK Seller”), ASTRAZENECA PHARMACEUTICALS LP, a Delaware limited partnership (the “US Seller”, and together with the Sweden Seller and the UK Seller, the “AZ Entities”), ENTASIS THERAPEUTICS LIMITED, a private limited company incorporated in England and Wales (the “UK Company”), and ENTASIS THERAPEUTICS INC., a Delaware corporation and a wholly owned subsidiary of the UK Company (the “US Company”, and together with the UK Company, the “Companies”). Capitalized terms not herein defined shall have the meanings ascribed to them in the Agreement (as defined below).
TRANSFER AND SUBSCRIPTION AGREEMENTTransfer and Subscription Agreement • November 10th, 2021 • 7 Acquisition Corp • Blank checks • New York
This Transfer and Subscription Agreement (this “Agreement”) is entered into as of [●], 2021, among 7 Acquisition Corporation, a Cayman Islands exempted company (the “Company”), 7 Acquisition Holdings, LLC, a Delaware limited liability company (the “Sponsor”), and [BlackRock Entity] (the “Purchaser”).
AMENDMENT TO AMENDED AND RESTATED BUSINESS TRANSFER AND SUBSCRIPTION AGREEMENTTransfer and Subscription Agreement • August 17th, 2018 • Entasis Therapeutics LTD • Pharmaceutical preparations
THIS AMENDMENT TO AMENDED AND RESTATED BUSINESS TRANSFER AND SUBSCRIPTION AGREEMENT (this “Amendment”) is made and entered into as of August 28, 2017 by and among ASTRAZENECA AB (PUBL), a company incorporated in Sweden under no. 556011-7482 (the “Sweden Seller”), ASTRAZENECA UK LIMITED, a company incorporated in England under no. 3674842 (the “UK Seller”), ASTRAZENECA PHARMACEUTICALS LP, a Delaware limited partnership (the “US Seller”, and together with the Sweden Seller and the UK Seller, the “AZ Entities”), ENTASIS THERAPEUTICS LIMITED, a private limited company incorporated in England and Wales (the “UK Company”), and ENTASIS THERAPEUTICS INC., a Delaware corporation and a wholly owned subsidiary of the UK Company (the “US Company”, and together with the UK Company, the “Companies”). Capitalized terms not herein defined shall have the meanings ascribed to them in the Agreement (as defined below).
Transfer and Subscription AgreementTransfer and Subscription Agreement • March 16th, 2018
Parties T2 Trust Name Taurus Funds Management Pty Limited as trustee for the Taurus Resources No. 2 Trust ACN 121 452 560 Incorporated in Australia Address Suite 4101, Level 41, Gateway1 Macquarie Place, Sydney, NSW, 2000 Attention The Directors BidCo Name T2 Resources Fund Pty Limited ACN 624 330 696 Incorporated in Australia
OLD MUTUAL ASSET MANAGERS (BERMUDA) LIMITED (7) ------------------------- PORTFOLIO TRANSFER AND SUBSCRIPTION AGREEMENT -------------------------Transfer and Subscription Agreement • November 9th, 1995 • Old Mutual South Africa Equity Trust • Massachusetts
